Singapore markets close in 5 hours 17 minutes

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.00-0.10 (-0.99%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 377.47M
Enterprise value 280.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.65
Price/book (mrq)2.98
Enterprise value/revenue -9.59
Enterprise value/EBITDA -2.75

Trading information

Stock price history

Beta (5Y monthly) 1.94
52-week change 370.03%
S&P500 52-week change 324.49%
52-week high 315.05
52-week low 31.81
50-day moving average 310.95
200-day moving average 36.06

Share statistics

Avg vol (3-month) 3261.49k
Avg vol (10-day) 3259.5k
Shares outstanding 537.86M
Implied shares outstanding 638.35M
Float 818.05M
% held by insiders 10.79%
% held by institutions 175.77%
Shares short (15 Apr 2024) 41.05M
Short ratio (15 Apr 2024) 43.24
Short % of float (15 Apr 2024) 45.85%
Short % of shares outstanding (15 Apr 2024) 42.77%
Shares short (prior month 15 Mar 2024) 4614.94k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 328 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-30.67%
Return on equity (ttm)-56.79%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -101.73M
Net income avi to common (ttm)-96.02M
Diluted EPS (ttm)-4.77
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.64M
Total cash per share (mrq)3.28
Total debt (mrq)26.27M
Total debt/equity (mrq)20.77%
Current ratio (mrq)8.94
Book value per share (mrq)6.20

Cash flow statement

Operating cash flow (ttm)-94.18M
Levered free cash flow (ttm)-64.43M